Up until now, Agencourt's main focus has been on DNA sequencing and sample prep. Cogenics, which has facilities in four countries, also provides genotyping, gene-expression analysis, biological efficacy and safety testing, and a biobanking facility.
The technology that Transgenomic has licensed is a variation of standard PCR technology that enriches mutations in samples where normal DNA predominates.
The company plans to move ahead with assay development projects for diagnosing Alzheimer's and Parkinson's disease, and for detecting KRAS mutations in colorectal, lung, and pancreatic cancer.
Clinical Data will use the funds to support late-stage development of two of its drugs.
The firm said it only has enough cash to fund its operations through March, and it is evaluating a number of options including the sale of non-core assets or another financing.
A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.
The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.
University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.
In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.